About LLC Arensia Exploratory Medicine
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Janssen Research & Development, LLC
4
Genentech, Inc.
2
Agenus Inc.
1
Alios Biopharma Inc.
1
Applied Molecular Transport
1
Eli Lilly and Company
1
GB004, Inc., a wholly owned subsidiary of Gossamer Bio, Inc.
1
Gilead Sciences
1
Hoffmann-La Roche
1
Modern Biosciences Ltd
1
Molecular Templates, Inc.
1
Clinical Trials at LLC Arensia Exploratory Medicine
During the past decade, LLC Arensia Exploratory Medicine conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 3 clinical trials were completed, i.e. on
average, 18.8% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 2 clinical trials were completed. i.e. 40%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Safety, PD & Efficacy of MT-3724 for the Treatment of Patients With Relapsed or Refractory DLBCL
2015-02-01
2021-03-22
Terminated
38
First in Human Study of AL-704; Single Dose, Food Effect in Healthy Volunteers; Multiple Doses in Chronic Hepatitis C
2015-07-31
2015-11-24
Terminated
42
Safety, Tolerability, and Efficacy of GS-9876 in Participants With Active Rheumatoid Arthritis on Background Therapy With Methotrexate
2016-09-21
2017-09-20
Completed
83
Safety, Tolerability and Efficacy of MBS2320 in Patients With Rheumatoid Arthritis
2017-05-30
2019-08-13
Completed
121
Subjects With Metastatic or Locally Advanced Solid Tumors, and Expansion Into Select Solid Tumors (Cervical)
2017-12-18
2022-07-15
Completed
154
A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3)
2018-07-18
2029-04-25
Recruiting
960
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of UTTR1147A Compared With Placebo and With Vedolizumab in Participants With Moderate to Severe Ulcerative Colitis (UC)
2018-10-26
2021-12-15
Completed
195
An Extension Study to Evaluate the Long-Term Safety and Tolerability of UTTR1147A in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease
2019-01-14
2022-07-12
Completed
143
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "LLC Arensia Exploratory Medicine" #1 sponsor was "Janssen Research & Development, LLC" with 4 trials, followed by "Genentech, Inc." with 2 trials
sponsored, "Agenus Inc." with 1 trials sponsored, "Alios Biopharma Inc." with 1 trials sponsored and "Applied Molecular Transport"
with 1 trials sponsored. Other sponsors include 2 different institutions and
companies that sponsored additional 12 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "LLC Arensia Exploratory Medicine"
#1 collaborator was "Janssen Pharmaceutica" with 1 trials as a collaborator and "Novotech Health Holdings Pte. Ltd." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at LLC Arensia Exploratory Medicine
According to Clinical.Site data, the most researched conditions in "LLC Arensia Exploratory Medicine" are
"Ulcerative Colitis" (5 trials), "Rheumatoid Arthritis" (3 trials), "Leukemia, Lymphocytic, Chronic, B-Cell" (2 trials), "Lymphoma, Non-Hodgkin" (2 trials) and "Blood Cancer" (1 trials). Many other conditions were trialed in "LLC Arensia Exploratory Medicine" in a lesser frequency.
Clinical Trials Intervention Types at LLC Arensia Exploratory Medicine
Most popular intervention types in "LLC Arensia Exploratory Medicine" are "Drug" (16 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "JNJ-64264681" (2 trials), "UTTR1147A" (2 trials), "AGEN1884 + AGEN2034" (1 trials) and "AL-704" (1 trials). Other intervention names were less common.
Clinical Trials Genders at LLC Arensia Exploratory Medicine
The vast majority of trials in "LLC Arensia Exploratory Medicine" are
14 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at LLC Arensia Exploratory Medicine
Currently, there are NaN active trials in "LLC Arensia Exploratory Medicine".
undefined are not yet recruiting,
3 are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 7 completed trials in LLC Arensia Exploratory Medicine,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in LLC Arensia Exploratory Medicine, 10 "Phase 1"
clinical trials were conducted, 7 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".